HER2-positive Advanced Breast Cancer Clinical Trials in Zhengzhou, Henan
2 recruitingZhengzhou, Henan, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
HER2-positive Advanced Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.416 enrolled69 locationsNCT07047365
Recruiting
Phase 2
Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases
HER2-positive Advanced Breast CancerBrain MetastasesRadiotherapy
Henan Cancer Hospital224 enrolled1 locationNCT07100600